 | • レポートコード：GIR-2104Z02679 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がん腫瘍プロファイリングのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん腫瘍プロファイリングの種類別市場規模（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、In Situハイブリダイゼーション（ISH）、マイクロアレイ、その他）、用途別市場規模（個別化医療、診断、バイオマーカー発見、予知、研究用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がん腫瘍プロファイリングの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Qiagen N.V.、Roche Molecular Systems Inc.、Abott Molecular、Illumina Inc.、NeoGenomics Laboratories、HTG Molecular Diagnostic、Genomic Health Inc.、Hologic Gen-Probe、BD Biosciences、Siemens Healthineers、Claris Life Sciences、Personal Genome Diagnostics, Inc.、Perthera, Inc.、Foundation Medicine, Inc、V., Strand、ApoCell、Contextual Genomics、Agendia、GenScript ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、In Situハイブリダイゼーション（ISH）、マイクロアレイ、その他 ・用途別分析2016年-2026年：個別化医療、診断、バイオマーカー発見、予知、研究用 ・がん腫瘍プロファイリングの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がん腫瘍プロファイリングのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん腫瘍プロファイリングのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん腫瘍プロファイリングの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がん腫瘍プロファイリングの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cancer Tumor Profiling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Tumor Profiling size is estimated to be USD 54970 million in 2025 from USD 37570 million in 2019, with a change XX% between 2019 and 2020. The global Cancer Tumor Profiling market size is expected to grow at a CAGR of 10.0% for the next five years.
Market segmentation
Cancer Tumor Profiling market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Market segment by Application, can be divided into
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Market segment by players, this report covers
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cancer Tumor Profiling
1.2 Classification of Cancer Tumor Profiling by Type
1.2.1 Overview: Global Cancer Tumor Profiling Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cancer Tumor Profiling Revenue Market Share by Type in 2020
1.2.3 Next-generation Sequencing (NGS)
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 Immunohistochemistry (IHC)
1.2.6 In Situ Hybridization (ISH)
1.2.7 Microarray
1.2.8 Others
1.3 Global Cancer Tumor Profiling Market by Application
1.3.1 Overview: Global Cancer Tumor Profiling Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Personalized Medicine
1.3.3 Diagnostics
1.3.4 Biomarker Discovery
1.3.5 Prognostics
1.3.6 Research Applications
1.4 Global Cancer Tumor Profiling Market Size & Forecast
1.5 Global Cancer Tumor Profiling Market Size and Forecast by Region
1.5.1 Global Cancer Tumor Profiling Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cancer Tumor Profiling Market Size by Region, (2016-2021)
1.5.3 North America Cancer Tumor Profiling Market Size and Prospect (2016-2026)
1.5.4 Europe Cancer Tumor Profiling Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cancer Tumor Profiling Market Size and Prospect (2016-2026)
1.5.6 South America Cancer Tumor Profiling Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cancer Tumor Profiling Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Tumor Profiling Market Drivers
1.6.2 Cancer Tumor Profiling Market Restraints
1.6.3 Cancer Tumor Profiling Trends Analysis
2 Company Profiles
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business
2.1.3 Qiagen N.V. Cancer Tumor Profiling Product and Solutions
2.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Qiagen N.V. Recent Developments and Future Plans
2.2 Roche Molecular Systems Inc.
2.2.1 Roche Molecular Systems Inc. Details
2.2.2 Roche Molecular Systems Inc. Major Business
2.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions
2.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Molecular Systems Inc. Recent Developments and Future Plans
2.3 Abott Molecular
2.3.1 Abott Molecular Details
2.3.2 Abott Molecular Major Business
2.3.3 Abott Molecular Cancer Tumor Profiling Product and Solutions
2.3.4 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abott Molecular Recent Developments and Future Plans
2.4 Illumina Inc.
2.4.1 Illumina Inc. Details
2.4.2 Illumina Inc. Major Business
2.4.3 Illumina Inc. Cancer Tumor Profiling Product and Solutions
2.4.4 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Illumina Inc. Recent Developments and Future Plans
2.5 NeoGenomics Laboratories
2.5.1 NeoGenomics Laboratories Details
2.5.2 NeoGenomics Laboratories Major Business
2.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions
2.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.6 HTG Molecular Diagnostic
2.6.1 HTG Molecular Diagnostic Details
2.6.2 HTG Molecular Diagnostic Major Business
2.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions
2.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 HTG Molecular Diagnostic Recent Developments and Future Plans
2.7 Genomic Health Inc.
2.7.1 Genomic Health Inc. Details
2.7.2 Genomic Health Inc. Major Business
2.7.3 Genomic Health Inc. Cancer Tumor Profiling Product and Solutions
2.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Genomic Health Inc. Recent Developments and Future Plans
2.8 Hologic Gen-Probe
2.8.1 Hologic Gen-Probe Details
2.8.2 Hologic Gen-Probe Major Business
2.8.3 Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions
2.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Hologic Gen-Probe Recent Developments and Future Plans
2.9 BD Biosciences
2.9.1 BD Biosciences Details
2.9.2 BD Biosciences Major Business
2.9.3 BD Biosciences Cancer Tumor Profiling Product and Solutions
2.9.4 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 BD Biosciences Recent Developments and Future Plans
2.10 Siemens Healthineers
2.10.1 Siemens Healthineers Details
2.10.2 Siemens Healthineers Major Business
2.10.3 Siemens Healthineers Cancer Tumor Profiling Product and Solutions
2.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Siemens Healthineers Recent Developments and Future Plans
2.11 Claris Life Sciences
2.11.1 Claris Life Sciences Details
2.11.2 Claris Life Sciences Major Business
2.11.3 Claris Life Sciences Cancer Tumor Profiling Product and Solutions
2.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Claris Life Sciences Recent Developments and Future Plans
2.12 Personal Genome Diagnostics, Inc.
2.12.1 Personal Genome Diagnostics, Inc. Details
2.12.2 Personal Genome Diagnostics, Inc. Major Business
2.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions
2.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Personal Genome Diagnostics, Inc. Recent Developments and Future Plans
2.13 Perthera, Inc.
2.13.1 Perthera, Inc. Details
2.13.2 Perthera, Inc. Major Business
2.13.3 Perthera, Inc. Cancer Tumor Profiling Product and Solutions
2.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Perthera, Inc. Recent Developments and Future Plans
2.14 Foundation Medicine, Inc
2.14.1 Foundation Medicine, Inc Details
2.14.2 Foundation Medicine, Inc Major Business
2.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions
2.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Foundation Medicine, Inc Recent Developments and Future Plans
2.15 V., Strand
2.15.1 V., Strand Details
2.15.2 V., Strand Major Business
2.15.3 V., Strand Cancer Tumor Profiling Product and Solutions
2.15.4 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 V., Strand Recent Developments and Future Plans
2.16 ApoCell
2.16.1 ApoCell Details
2.16.2 ApoCell Major Business
2.16.3 ApoCell Cancer Tumor Profiling Product and Solutions
2.16.4 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 ApoCell Recent Developments and Future Plans
2.17 Contextual Genomics
2.17.1 Contextual Genomics Details
2.17.2 Contextual Genomics Major Business
2.17.3 Contextual Genomics Cancer Tumor Profiling Product and Solutions
2.17.4 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Contextual Genomics Recent Developments and Future Plans
2.18 Agendia
2.18.1 Agendia Details
2.18.2 Agendia Major Business
2.18.3 Agendia Cancer Tumor Profiling Product and Solutions
2.18.4 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Agendia Recent Developments and Future Plans
2.19 GenScript
2.19.1 GenScript Details
2.19.2 GenScript Major Business
2.19.3 GenScript Cancer Tumor Profiling Product and Solutions
2.19.4 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 GenScript Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Tumor Profiling Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Tumor Profiling Players Market Share
3.2.2 Top 10 Cancer Tumor Profiling Players Market Share
3.2.3 Market Competition Trend
3.3 Cancer Tumor Profiling Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Tumor Profiling Revenue and Market Share by Type (2016-2021)
4.2 Global Cancer Tumor Profiling Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cancer Tumor Profiling Revenue Market Share by Application (2016-2021)
5.2 Cancer Tumor Profiling Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Tumor Profiling Revenue by Type (2016-2026)
6.2 North America Cancer Tumor Profiling Revenue by Application (2016-2026)
6.3 North America Cancer Tumor Profiling Market Size by Country
6.3.1 North America Cancer Tumor Profiling Revenue by Country (2016-2026)
6.3.2 United States Cancer Tumor Profiling Market Size and Forecast (2016-2026)
6.3.3 Canada Cancer Tumor Profiling Market Size and Forecast (2016-2026)
6.3.4 Mexico Cancer Tumor Profiling Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Tumor Profiling Revenue by Type (2016-2026)
7.2 Europe Cancer Tumor Profiling Revenue by Application (2016-2026)
7.3 Europe Cancer Tumor Profiling Market Size by Country
7.3.1 Europe Cancer Tumor Profiling Revenue by Country (2016-2026)
7.3.2 Germany Cancer Tumor Profiling Market Size and Forecast (2016-2026)
7.3.3 France Cancer Tumor Profiling Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cancer Tumor Profiling Market Size and Forecast (2016-2026)
7.3.5 Russia Cancer Tumor Profiling Market Size and Forecast (2016-2026)
7.3.6 Italy Cancer Tumor Profiling Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Tumor Profiling Revenue by Type (2016-2026)
8.2 Asia-Pacific Cancer Tumor Profiling Revenue by Application (2016-2026)
8.3 Asia-Pacific Cancer Tumor Profiling Market Size by Region
8.3.1 Asia-Pacific Cancer Tumor Profiling Revenue by Region (2016-2026)
8.3.2 China Cancer Tumor Profiling Market Size and Forecast (2016-2026)
8.3.3 Japan Cancer Tumor Profiling Market Size and Forecast (2016-2026)
8.3.4 South Korea Cancer Tumor Profiling Market Size and Forecast (2016-2026)
8.3.5 India Cancer Tumor Profiling Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cancer Tumor Profiling Market Size and Forecast (2016-2026)
8.3.7 Australia Cancer Tumor Profiling Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Tumor Profiling Revenue by Type (2016-2026)
9.2 South America Cancer Tumor Profiling Revenue by Application (2016-2026)
9.3 South America Cancer Tumor Profiling Market Size by Country
9.3.1 South America Cancer Tumor Profiling Revenue by Country (2016-2026)
9.3.2 Brazil Cancer Tumor Profiling Market Size and Forecast (2016-2026)
9.3.3 Argentina Cancer Tumor Profiling Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Tumor Profiling Revenue by Type (2016-2026)
10.2 Middle East & Africa Cancer Tumor Profiling Revenue by Application (2016-2026)
10.3 Middle East & Africa Cancer Tumor Profiling Market Size by Country
10.3.1 Middle East & Africa Cancer Tumor Profiling Revenue by Country (2016-2026)
10.3.2 Turkey Cancer Tumor Profiling Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cancer Tumor Profiling Market Size and Forecast (2016-2026)
10.3.4 UAE Cancer Tumor Profiling Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cancer Tumor Profiling Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cancer Tumor Profiling Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cancer Tumor Profiling Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cancer Tumor Profiling Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cancer Tumor Profiling Revenue Market Share by Region (2021-2026)
Table 6. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 7. Qiagen N.V. Major Business
Table 8. Qiagen N.V. Cancer Tumor Profiling Product and Solutions
Table 9. Qiagen N.V. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Molecular Systems Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Roche Molecular Systems Inc. Major Business
Table 12. Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions
Table 13. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abott Molecular Corporate Information, Head Office, and Major Competitors
Table 15. Abott Molecular Major Business
Table 16. Abott Molecular Cancer Tumor Profiling Product and Solutions
Table 17. Abott Molecular Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Illumina Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Illumina Inc. Major Business
Table 20. Illumina Inc. Cancer Tumor Profiling Product and Solutions
Table 21. Illumina Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. NeoGenomics Laboratories Corporate Information, Head Office, and Major Competitors
Table 23. NeoGenomics Laboratories Major Business
Table 24. NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions
Table 25. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. HTG Molecular Diagnostic Corporate Information, Head Office, and Major Competitors
Table 27. HTG Molecular Diagnostic Major Business
Table 28. HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions
Table 29. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Genomic Health Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Genomic Health Inc. Major Business
Table 32. Genomic Health Inc. Cancer Tumor Profiling Product and Solutions
Table 33. Genomic Health Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Hologic Gen-Probe Corporate Information, Head Office, and Major Competitors
Table 35. Hologic Gen-Probe Major Business
Table 36. Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions
Table 37. Hologic Gen-Probe Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. BD Biosciences Corporate Information, Head Office, and Major Competitors
Table 39. BD Biosciences Major Business
Table 40. BD Biosciences Cancer Tumor Profiling Product and Solutions
Table 41. BD Biosciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
Table 43. Siemens Healthineers Major Business
Table 44. Siemens Healthineers Cancer Tumor Profiling Product and Solutions
Table 45. Siemens Healthineers Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Claris Life Sciences Corporate Information, Head Office, and Major Competitors
Table 47. Claris Life Sciences Major Business
Table 48. Claris Life Sciences Cancer Tumor Profiling Product and Solutions
Table 49. Claris Life Sciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Personal Genome Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Personal Genome Diagnostics, Inc. Major Business
Table 52. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions
Table 53. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Perthera, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Perthera, Inc. Major Business
Table 56. Perthera, Inc. Cancer Tumor Profiling Product and Solutions
Table 57. Perthera, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Foundation Medicine, Inc Corporate Information, Head Office, and Major Competitors
Table 59. Foundation Medicine, Inc Major Business
Table 60. Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions
Table 61. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. V., Strand Corporate Information, Head Office, and Major Competitors
Table 63. V., Strand Major Business
Table 64. V., Strand Cancer Tumor Profiling Product and Solutions
Table 65. V., Strand Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. ApoCell Corporate Information, Head Office, and Major Competitors
Table 67. ApoCell Major Business
Table 68. ApoCell Cancer Tumor Profiling Product and Solutions
Table 69. ApoCell Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Contextual Genomics Corporate Information, Head Office, and Major Competitors
Table 71. Contextual Genomics Major Business
Table 72. Contextual Genomics Cancer Tumor Profiling Product and Solutions
Table 73. Contextual Genomics Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Agendia Corporate Information, Head Office, and Major Competitors
Table 75. Agendia Major Business
Table 76. Agendia Cancer Tumor Profiling Product and Solutions
Table 77. Agendia Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. GenScript Corporate Information, Head Office, and Major Competitors
Table 79. GenScript Major Business
Table 80. GenScript Cancer Tumor Profiling Product and Solutions
Table 81. GenScript Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Global Cancer Tumor Profiling Revenue (USD Million) by Players (2019-2021)
Table 83. Global Cancer Tumor Profiling Revenue Share by Players (2019-2021)
Table 84. Breakdown of Cancer Tumor Profiling by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Cancer Tumor Profiling Players Head Office, Products and Services Provided
Table 86. Cancer Tumor Profiling Mergers & Acquisitions in the Past Five Years
Table 87. Cancer Tumor Profiling New Entrants and Expansion Plans
Table 88. Global Cancer Tumor Profiling Revenue (USD Million) by Type (2016-2021)
Table 89. Global Cancer Tumor Profiling Revenue Share by Type (2016-2021)
Table 90. Global Cancer Tumor Profiling Revenue Forecast by Type (2021-2026)
Table 91. Global Cancer Tumor Profiling Revenue by Application (2016-2021)
Table 92. Global Cancer Tumor Profiling Revenue Forecast by Application (2021-2026)
Table 93. North America Cancer Tumor Profiling Revenue by Type (2016-2021) & (USD Million)
Table 94. North America Cancer Tumor Profiling Revenue by Type (2021-2026) & (USD Million)
Table 95. North America Cancer Tumor Profiling Revenue by Application (2016-2021) & (USD Million)
Table 96. North America Cancer Tumor Profiling Revenue by Application (2021-2026) & (USD Million)
Table 97. North America Cancer Tumor Profiling Revenue by Country (2016-2021) & (USD Million)
Table 98. North America Cancer Tumor Profiling Revenue by Country (2021-2026) & (USD Million)
Table 99. Europe Cancer Tumor Profiling Revenue by Type (2016-2021) & (USD Million)
Table 100. Europe Cancer Tumor Profiling Revenue by Type (2021-2026) & (USD Million)
Table 101. Europe Cancer Tumor Profiling Revenue by Application (2016-2021) & (USD Million)
Table 102. Europe Cancer Tumor Profiling Revenue by Application (2021-2026) & (USD Million)
Table 103. Europe Cancer Tumor Profiling Revenue by Country (2016-2021) & (USD Million)
Table 104. Europe Cancer Tumor Profiling Revenue by Country (2021-2026) & (USD Million)
Table 105. Asia-Pacific Cancer Tumor Profiling Revenue by Type (2016-2021) & (USD Million)
Table 106. Asia-Pacific Cancer Tumor Profiling Revenue by Type (2021-2026) & (USD Million)
Table 107. Asia-Pacific Cancer Tumor Profiling Revenue by Application (2016-2021) & (USD Million)
Table 108. Asia-Pacific Cancer Tumor Profiling Revenue by Application (2021-2026) & (USD Million)
Table 109. Asia-Pacific Cancer Tumor Profiling Revenue by Region (2016-2021) & (USD Million)
Table 110. Asia-Pacific Cancer Tumor Profiling Revenue by Region (2021-2026) & (USD Million)
Table 111. South America Cancer Tumor Profiling Revenue by Type (2016-2021) & (USD Million)
Table 112. South America Cancer Tumor Profiling Revenue by Type (2021-2026) & (USD Million)
Table 113. South America Cancer Tumor Profiling Revenue by Application (2016-2021) & (USD Million)
Table 114. South America Cancer Tumor Profiling Revenue by Application (2021-2026) & (USD Million)
Table 115. South America Cancer Tumor Profiling Revenue by Country (2016-2021) & (USD Million)
Table 116. South America Cancer Tumor Profiling Revenue by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Cancer Tumor Profiling Revenue by Type (2016-2021) & (USD Million)
Table 118. Middle East & Africa Cancer Tumor Profiling Revenue by Type (2021-2026) & (USD Million)
Table 119. Middle East & Africa Cancer Tumor Profiling Revenue by Application (2016-2021) & (USD Million)
Table 120. Middle East & Africa Cancer Tumor Profiling Revenue by Application (2021-2026) & (USD Million)
Table 121. Middle East & Africa Cancer Tumor Profiling Revenue by Country (2016-2021) & (USD Million)
Table 122. Middle East & Africa Cancer Tumor Profiling Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cancer Tumor Profiling Picture
Figure 2. Global Cancer Tumor Profiling Revenue Market Share by Type in 2020
Figure 3. Next-generation Sequencing (NGS)
Figure 4. Polymerase Chain Reaction (PCR)
Figure 5. Immunohistochemistry (IHC)
Figure 6. In Situ Hybridization (ISH)
Figure 7. Microarray
Figure 8. Others
Figure 9. Cancer Tumor Profiling Revenue Market Share by Application in 2020
Figure 10. Personalized Medicine Picture
Figure 11. Diagnostics Picture
Figure 12. Biomarker Discovery Picture
Figure 13. Prognostics Picture
Figure 14. Research Applications Picture
Figure 15. Global Cancer Tumor Profiling Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global Cancer Tumor Profiling Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global Cancer Tumor Profiling Revenue Market Share by Region (2016-2026)
Figure 18. Global Cancer Tumor Profiling Revenue Market Share by Region in 2020
Figure 19. North America Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Cancer Tumor Profiling Market Drivers
Figure 24. Cancer Tumor Profiling Market Restraints
Figure 25. Cancer Tumor Profiling Market Trends
Figure 26. Qiagen N.V. Recent Developments and Future Plans
Figure 27. Roche Molecular Systems Inc. Recent Developments and Future Plans
Figure 28. Abott Molecular Recent Developments and Future Plans
Figure 29. Illumina Inc. Recent Developments and Future Plans
Figure 30. NeoGenomics Laboratories Recent Developments and Future Plans
Figure 31. HTG Molecular Diagnostic Recent Developments and Future Plans
Figure 32. Genomic Health Inc. Recent Developments and Future Plans
Figure 33. Hologic Gen-Probe Recent Developments and Future Plans
Figure 34. BD Biosciences Recent Developments and Future Plans
Figure 35. Siemens Healthineers Recent Developments and Future Plans
Figure 36. Claris Life Sciences Recent Developments and Future Plans
Figure 37. Personal Genome Diagnostics, Inc. Recent Developments and Future Plans
Figure 38. Perthera, Inc. Recent Developments and Future Plans
Figure 39. Foundation Medicine, Inc Recent Developments and Future Plans
Figure 40. V., Strand Recent Developments and Future Plans
Figure 41. ApoCell Recent Developments and Future Plans
Figure 42. Contextual Genomics Recent Developments and Future Plans
Figure 43. Agendia Recent Developments and Future Plans
Figure 44. GenScript Recent Developments and Future Plans
Figure 46. Global Cancer Tumor Profiling Revenue Share by Players in 2020
Figure 47. Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 48. Global Top 3 Players Cancer Tumor Profiling Revenue Market Share in 2020
Figure 49. Global Top 10 Players Cancer Tumor Profiling Revenue Market Share in 2020
Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 51. Global Cancer Tumor Profiling Revenue Share by Type in 2020
Figure 52. Global Cancer Tumor Profiling Market Share Forecast by Type (2021-2026)
Figure 53. Global Cancer Tumor Profiling Revenue Share by Application in 2020
Figure 54. Global Cancer Tumor Profiling Market Share Forecast by Application (2021-2026)
Figure 55. North America Cancer Tumor Profiling Sales Market Share by Type (2016-2026)
Figure 56. North America Cancer Tumor Profiling Sales Market Share by Application (2016-2026)
Figure 57. North America Cancer Tumor Profiling Revenue Market Share by Country (2016-2026)
Figure 58. United States Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Canada Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Mexico Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Europe Cancer Tumor Profiling Sales Market Share by Type (2016-2026)
Figure 62. Europe Cancer Tumor Profiling Sales Market Share by Application (2016-2026)
Figure 63. Europe Cancer Tumor Profiling Revenue Market Share by Country (2016-2026)
Figure 64. Germany Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. France Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. United Kingdom Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Russia Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Italy Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Asia-Pacific Cancer Tumor Profiling Sales Market Share by Type (2016-2026)
Figure 70. Asia-Pacific Cancer Tumor Profiling Sales Market Share by Application (2016-2026)
Figure 71. Asia-Pacific Cancer Tumor Profiling Revenue Market Share by Region (2016-2026)
Figure 72. China Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Japan Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Korea Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. India Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Southeast Asia Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Australia Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South America Cancer Tumor Profiling Sales Market Share by Type (2016-2026)
Figure 79. South America Cancer Tumor Profiling Sales Market Share by Application (2016-2026)
Figure 80. South America Cancer Tumor Profiling Revenue Market Share by Country (2016-2026)
Figure 81. Brazil Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Argentina Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Middle East and Africa Cancer Tumor Profiling Sales Market Share by Type (2016-2026)
Figure 84. Middle East and Africa Cancer Tumor Profiling Sales Market Share by Application (2016-2026)
Figure 85. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Country (2016-2026)
Figure 86. Turkey Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Saudi Arabia Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. UAE Cancer Tumor Profiling Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. Methodology
Figure 90. Research Process and Data Source
世界のがん（腫瘍）プロファイリング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer (Tumor) Profiling Market The global Cancer (Tumor) Profiling market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …- 世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 世界の腫瘍バイオマーカー検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 世界の歯原性腫瘍市場規模・現状・予測（2021年-2027年） Odontogenic tumors (OT) are a heterogeneous group of lesions of diverse clinical behavior and histopathologic types, ranging from hamartomatous lesions to malignancy. The odontogenic tumor is an abnormal growth of tissues in jaws and around the teeth. Odontogenic tumors are malignant, which means th…